U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446400) titled 'A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together' on Feb. 25.
Brief Summary: The purpose of this study is to assess the drug-drug interaction (DDI) of repinatrabit with ethinyl estradiol/norethindrone or norethisterone (EE/NE), metformin, rosuvastatin, carbamazepine, and methotrexate in healthy participants.
Study Start Date: March 20
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Repinatrabit
Oral tablet.
DRUG: EE/NE
Oral tablet.
DRUG: Metformin
Oral tablet.
DRUG: Rosuv...